DK0887349T3 - Tetrahydroimidazo[2,1-a]isoquinolinderivater - Google Patents

Tetrahydroimidazo[2,1-a]isoquinolinderivater

Info

Publication number
DK0887349T3
DK0887349T3 DK98202076T DK98202076T DK0887349T3 DK 0887349 T3 DK0887349 T3 DK 0887349T3 DK 98202076 T DK98202076 T DK 98202076T DK 98202076 T DK98202076 T DK 98202076T DK 0887349 T3 DK0887349 T3 DK 0887349T3
Authority
DK
Denmark
Prior art keywords
tetrahydroimidazo
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
DK98202076T
Other languages
English (en)
Inventor
Dirk Leysen
Gerardus Stephanus Franc Ruigt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0887349T3 publication Critical patent/DK0887349T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98202076T 1997-06-26 1998-06-23 Tetrahydroimidazo[2,1-a]isoquinolinderivater DK0887349T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201950 1997-06-26

Publications (1)

Publication Number Publication Date
DK0887349T3 true DK0887349T3 (da) 2002-03-25

Family

ID=8228485

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98202076T DK0887349T3 (da) 1997-06-26 1998-06-23 Tetrahydroimidazo[2,1-a]isoquinolinderivater

Country Status (27)

Country Link
US (1) US5994366A (da)
EP (1) EP0887349B1 (da)
JP (1) JP4339939B2 (da)
KR (1) KR100540317B1 (da)
CN (1) CN1139589C (da)
AR (1) AR013132A1 (da)
AT (1) ATE209649T1 (da)
AU (1) AU737924B2 (da)
BR (1) BR9802286A (da)
CA (1) CA2241469C (da)
CZ (1) CZ293265B6 (da)
DE (1) DE69802624T2 (da)
DK (1) DK0887349T3 (da)
ES (1) ES2169471T3 (da)
HK (1) HK1018059A1 (da)
HU (1) HUP9801451A3 (da)
ID (1) ID20494A (da)
IL (1) IL124914A (da)
NO (1) NO311028B1 (da)
NZ (1) NZ330722A (da)
PL (1) PL190281B1 (da)
PT (1) PT887349E (da)
RU (1) RU2204560C2 (da)
SG (1) SG66484A1 (da)
TR (1) TR199801175A1 (da)
TW (1) TW513411B (da)
ZA (1) ZA985559B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624093A (en) * 1970-03-10 1971-11-30 American Home Prod 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols
US4100165A (en) * 1975-06-17 1978-07-11 Sandoz, Inc. Imidazo [2,1-a]isoquinolines

Also Published As

Publication number Publication date
HUP9801451A2 (hu) 1999-02-01
TR199801175A1 (xx) 1999-01-18
KR19990007323A (ko) 1999-01-25
HK1018059A1 (en) 1999-12-10
SG66484A1 (en) 1999-07-20
CZ204898A3 (cs) 1999-08-11
IL124914A0 (en) 1999-01-26
PT887349E (pt) 2002-04-29
HUP9801451A3 (en) 1999-03-29
EP0887349B1 (en) 2001-11-28
CN1203916A (zh) 1999-01-06
NO982952L (no) 1998-12-28
NO982952D0 (no) 1998-06-25
NO311028B1 (no) 2001-10-01
ES2169471T3 (es) 2002-07-01
DE69802624D1 (de) 2002-01-10
JPH1171373A (ja) 1999-03-16
EP0887349A1 (en) 1998-12-30
US5994366A (en) 1999-11-30
RU2204560C2 (ru) 2003-05-20
KR100540317B1 (ko) 2006-04-17
ZA985559B (en) 1999-01-20
TW513411B (en) 2002-12-11
AU737924B2 (en) 2001-09-06
CA2241469C (en) 2008-08-19
PL327053A1 (en) 1999-01-04
NZ330722A (en) 1999-08-30
DE69802624T2 (de) 2002-08-01
ATE209649T1 (de) 2001-12-15
IL124914A (en) 2000-10-31
HU9801451D0 (en) 1998-08-28
BR9802286A (pt) 2000-02-08
CA2241469A1 (en) 1998-12-26
AU7319698A (en) 1999-01-07
CZ293265B6 (cs) 2004-03-17
PL190281B1 (pl) 2005-11-30
CN1139589C (zh) 2004-02-25
AR013132A1 (es) 2000-12-13
JP4339939B2 (ja) 2009-10-07
ID20494A (id) 1998-12-31

Similar Documents

Publication Publication Date Title
PT1005446E (pt) Derivados de n-aroilfenilalanina
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
PT915088E (pt) Derivados de d-prolina
DE69804273D1 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
ATE440854T1 (de) 5-deoxy-cytidin-derivate
NO307708B1 (no) Ferrocenderivater
DE69811367T2 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653D0 (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
PT966437E (pt) Derivados de 5-aroilnaftaleno
ZA9810039B (en) Azoline derivatives
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DK0887349T3 (da) Tetrahydroimidazo[2,1-a]isoquinolinderivater
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
DE69711853D1 (de) Pyridincarboxamid-derivate
NO970431D0 (no) Tetrahydroisokinolin-derivater
KR970052678U (ko) 피리리드
BR1100219A (pt) Derivados de diidropiridina